@article{SeitzerKlapperMazigoetal.2021,
  author    = {Seitzer, Moritz and Klapper, Sylvia and Mazigo, Humphrey D. and Holzgrabe, Ulrike and Mueller, Andreas},
  title     = {Quality and composition of Albendazole, Mebendazole and Praziquantel available in Burkina Faso, C{\^o}te d'Ivoire, Ghana and Tanzania},
  series = {PLoS Neglected Tropical Diseases},
  volume    = {15},
  journal   = {PLoS Neglected Tropical Diseases},
  number    = {1},
  doi       = {10.1371/journal.pntd.0009038},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-270434},
  year      = {2021},
  abstract  = {Background Even though the international combat against Neglected Tropical Diseases such as schistosomiasis or soil-transmitted helminthiases depends on reliable therapeutics, anthelminthic pharmacovigilance has been neglected on many national African drug markets. Therefore, quality and composition of Albendazole, Mebendazole and Praziquantel locally collected in Burkina Faso, C{\^o}te d'Ivoire, Ghana and Tanzania were analysed. Methods Samples of 88 different batches were obtained from randomly selected facilities. Sampling took place in Northwest Tanzania, Western Burkina Faso, Southeast C{\^o}te d'Ivoire and Southwest Ghana. Visual examination of both packaging and samples was performed according to the WHO 'Be Aware' tool. Products were then screened with the GPHF Minilab, consisting of tests of mass uniformity, disintegration times and thin-layer chromatography (TLC). Confirmatory tests were performed according to international pharmacopoeiae, applying assays for dissolution profiles and high-performance liquid chromatography (HPLC). Findings Despite minor irregularities, appearance of the products did not hint at falsified medicines. However, 19.6\% of the brands collected in Ghana and Tanzania were not officially licensed for sale. Mass uniformity was confirmed in 53 out of 58 brands of tablets. 41 out of 56 products passed disintegration times; 10 out of the 15 failing products did not disintegrate at all. Evaluating TLC results, only 4 out of 83 batches narrowly missed specification limits, 18 batches slightly exceeded them. Not more than 46.3\% (31 / 67) of the tablets assayed passed the respective pharmaceutical criteria for dissolution. HPLC findings confirmed TLC results despite shifted specification limits: 10 out of 83 tested batches contained less than 90\%, none exceeded 110\%. Conclusion In the four study countries, no falsified anthelminthic medicine was encountered. The active pharmaceutical ingredient was not found to either exceed or fall below specification limits. Galenic characteristics however, especially dissolution profiles, revealed great deficits.},
  language  = {en}
}
@article{AbdelhafezFawzyFahimetal.2018,
  author    = {Abdelhafez, Omnia Hesham and Fawzy, Michael Atef and Fahim, John Refaat and Desoukey, Samar Yehia and Krischke, Markus and Mueller, Martin J. and Abdelmohsen, Usama Ramadan},
  title     = {Hepatoprotective potential of Malvaviscus arboreus against carbon tetrachloride-induced liver injury in rats},
  series = {PLoS ONE},
  volume    = {13},
  journal   = {PLoS ONE},
  number    = {8},
  doi       = {10.1371/journal.pone.0202362},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-177243},
  pages     = {e0202362},
  year      = {2018},
  abstract  = {Malvaviscus arboreus Cav. is a medicinal plant belonging to family Malvaceae with both ethnomedical and culinary value; however, its phytochemical and biological profiles have been scarcely studied. Accordingly, this work was designed to explore the chemical composition and the hepatoprotective potential of M. arboreus against carbon tetrachloride (CCl\(_4\))-induced hepatotoxicity. The total extract of the aerial parts and its derived fractions (petroleum ether, dichloromethane, ethyl acetate, and aqueous) were orally administered to rats for six consecutive days, followed by injection of CCl\(_4\) (1:1 v/v, in olive oil, 1.5 ml/kg, i.p.) on the next day. Results showed that the ethyl acetate and dichloromethane fractions significantly alleviated liver injury in rats as indicated by the reduced levels of alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP), total bilirubin (TB), and malondialdehyde (MDA), along with enhancement of the total antioxidant capacities of their livers, with the maximum effects were recorded by the ethyl acetate fraction. Moreover, the protective actions of both fractions were comparable to those of silymarin (100 mg/kg), and have been also substantiated by histopathological evaluations. On the other hand, liquid chromatography-high resolution electrospray ionization mass spectrometry (LC‒HR‒ESI‒MS) metabolomic profiling of the crude extract of M. arboreus aerial parts showed the presence of a variety of phytochemicals, mostly phenolics, whereas the detailed chemical analysis of the most active fraction (i.e. ethyl acetate) resulted in the isolation and identification of six compounds for the first time in the genus, comprising four phenolic acids; β-resorcylic, caffeic, protocatechuic, and 4-hydroxyphenylacetic acids, in addition to two flavonoids; trifolin and astragalin. Such phenolic principles, together with their probable synergistic antioxidant and liver-protecting properties, seem to contribute to the observed hepatoprotective potential of M. arboreus.},
  language  = {en}
}